Exact Sciences Corp. (NASDAQ: EXAS) dropped 26% on Thursday to post a new 52-week low at $7.41 after closing at $10.02 on Wednesday. The stock’s 52-week high is $32.85. Share volume was more than 7 times the daily average of around 2 million. The company continues to get smacked after its colon cancer drug failed to make a list of recommended treatments.
GoPro Inc. (NASDAQ: GPRO) dropped 7.7% on Thursday to post a new 52-week low of $27.07 against a 52-week high of $92.38. The stock closed at $29.33 on Wednesday night. Volume was approaching double the daily average of around 9.7 million shares traded. The company’s price target was cut by half at Morgan Stanley yesterday, and the bloodletting continues.
Cardiovascular Systems Inc. (NASDAQ: CSII) dropped 29% on Thursday to post a new 52-week low of $11.80 against a high of $41.28. The stock closed at $16.63 on Wednesday night. Volume was more than 20 times the daily average of around 390,000 shares traded. The company reported weak preliminary quarterly results after markets closed last night.
The Spectranetics Corp. (NASDAQ: SPNC) posted a new low on Thursday. Shares dropped about 8.9% to a low of $10.79 from Wednesday’s closing price of $11.85. The stock’s 52-week high is $37.04. Volume was about 50% above the daily average of around 920,000. The company had no specific news today.
ALSO READ: 10 States Draining the Country’s Energy
Get Ready To Retire (Sponsored)
Start by taking a quick retirement quiz from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes, or less.
Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests.
Here’s how it works:
1. Answer SmartAsset advisor match quiz
2. Review your pre-screened matches at your leisure. Check out the advisors’ profiles.
3. Speak with advisors at no cost to you. Have an introductory call on the phone or introduction in person and choose whom to work with in the future
Get started right here.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
